This QuickCounsel shows how US employers can do better by proactively implementing policies and programs that are inclusive of the transgender community.
This Quick Overview (formerly QuickCounsel) identifies practical steps for effective contract management for the benefit of a contracting party in France.
This QuickCounsel examines the key provisions of the proposed GDPR and identifies some of the more relevant obligations which in-house counsel will need to consider under the new regime.
This QuickCounsel discusses the transaction terms Earn-Outs and MAE Conditions in mergers and acquisitions transactions at a high-level with a view to how buyers and sellers/targets are likely to view and negotiate these terms.
Many employers have implemented education and employee disciplinary guidelines to address workplace violence in the United States. While both are important, they often fail to provide employees with tools that could prevent one of the root causes of workplace violence: impacts of early trauma.
This QuickCounsel aims at studying three main themes of the French Civil Code reform: the acknowledgment of the concept of significant imbalance, the recognition of the unforeseeability doctrine and the installation of a new legal regime regarding the price.
The purpose of this article is to present a general analysis of the labor inspections that the Ministry of Labor and Social Welfare may perform in the workplaces and companies' sites in order to verify the compliance of the relevant provisions established in the Federal Labor Law, the regulation of labor inspections and application of fines, sanctions and other Mexican legal bodies.
This Top Ten lists the steps that transactional attorneys can take to avoid common pitfalls when drafting risk allocation provisions.
After describing the legal rules that apply to a contract in case of a change of legislation, this QuickCounsel will examine provisions that clarify which law will apply to the contract over time.
This quick overview (QuickCounsel) describes how the U.S. Food and Drug Administration ("FDA") regulates the pre-marketing process for drugs and medical devices, and the steps that must be taken to obtain FDA authorization to market these products.